Edited by Arthur Weiss, University of California, San Francisco, CA, and approved June 16, 2011 (received for review March 16, 2011) Activation of the small G protein Ras is required for thymocyte differentiation. In thymocytes, Ras is activated by the Ras guanine exchange factors (RasGEFs) Sos1, Sos2, and RasGRP1. We report the development of a floxed allele of sos1 to assess the role of Sos1 during thymocyte development. Sos1 was required for pre-T-cell receptor (pre-TCR)-but not TCR-stimulated developmental signals. Sos1 deletion led to a partial block at the DN-to-DP transition. Sos1-deficient thymocytes showed reduced pre-TCR-stimulated proliferation, differentiation, and ERK phosphorylation. In contrast, TCRstimulated positive selection, and negative selection under strong stimulatory conditions, remained intact in Sos1-deficient mice. Comparison of RasGEF expression at different developmental stages showed that relative to Sos2 and RasGRP1, Sos1 is most abundant in DN thymocytes, but least abundant in DP thymocytes. These data reveal that Sos1 is uniquely positioned to affect signal transduction early in thymocyte development.
Son of Sevenless | β-selection | conditional knockout | Cre | lymphocyte signaling R as activation underlies numerous signaling, developmental, and oncogenic systems (1) (2) (3) . The small G protein Ras is active when it is GTP bound, and its activation is catalyzed by guanine exchange factors (GEFs), which release GDP from inactive Ras, allowing Ras to bind GTP. Ras inactivation is mediated by its intrinsic GTPase activity, which is facilitated by Ras GTPase-activating proteins (RasGAPs). Activated Ras proteins signal via a number of effector pathways to regulate varied biological processes, depending upon cellular context (1) . In thymocytes, Ras functions downstream of two receptors, the pre-Tcell receptor (pre-TCR) and the TCR to regulate a series of maturation steps (4) (5) (6) .
T-cell development is initiated when immature, progenitor cells migrate from the fetal liver and bone marrow to the thymus where they undergo differentiation and emerge as mature T cells. Thymocyte development can be followed by the variable expression of the cell surface markers CD4 and CD8. The most immature thymic T cells are CD4 (7) . There are at least two checkpoints in T-cell development, which serve to ensure proper TCR surface expression and T-cell function (7) . The first occurs at the DN3 stage of thymocyte development and is a process known as β-selection. At this point, a properly rearranged TCRβ chain pairs with pre-TCRα (pTα) to form the pre-TCR, which signals in a ligand-independent manner to drive proliferation and differentiation to the DP stage (8) . The second developmental checkpoint occurs at the DP stage. Following expression of a mature αβTCR on the cell surface, the strength and quality of signaling through the mature receptor is interrogated (9) . Cells that fail to signal through the mature TCR die by neglect; cells that recognize self-antigen and self-MHC in the thymus generate strong TCR signaling responses and die via TCRmediated apoptotic pathways (negative selection); and cells with a weak affinity to antigen and self-MHC signal weakly and selectively survive (positive selection). Genetic studies have shown that signaling from either the pre-TCR or TCR, through the adaptors LAT and Slp-76, to the Ras/ERK cascade is required at both developmental checkpoints (5, 6, (10) (11) (12) .
Although studied for 20 years, how the Ras/ERK cascade is activated during thymocyte development is not well understood. Ras signaling in thymocytes is thought to be regulated by two families of RasGEFs: Sos (Son of Sevenless) and RasGRP1 (4, 13) . Sos proteins are ubiquitously expressed, and are recruited to receptors and adaptor proteins phosphorylated on tyrosines via the adaptor Grb2. In contrast, RasGRP1 expression is limited to lymphoid and neural tissue (1). RasGRP1 is activated by phosphorylation and by binding to diacylglycerol (3) . RasGRP1
−/− mice show a complete block in positive selection, but development to the DP stage is normal, suggesting that RasGRP1 is not required for pre-TCR-mediated thymocyte development (14) . The precise role of the two Sos isoforms in T-cell development, however, has not been established. Sos2
−/− mice are phenotypically normal, but their thymocyte development has not been assessed (15) , whereas Sos1 −/− mice die in utero of a placental defect (16, 17) . Here, we report the development of a floxed allele of sos1, and use this model to assess the role of Sos1 during thymocyte development. Deletion of Sos1 early in thymocyte development leads to a partial developmental block at the DN-to-DP transition. These mice show reduced pre-TCR-stimulated proliferation and differentiation, although other aspects of pre-TCR-mediated development are unaffected. Finally, we show that the ratio of Sos1 to RasGRP1 expression markedly changes between DN3 and DP thymocytes. This nonoverlapping expression of RasGEFs underlies the importance of Sos1 in early pre-TCR-mediated developmental signaling.
Results
To assess the role of Sos1 in thymocyte development, we generated sos1-targeted mice with exon 10 of sos1 flanked by LoxP sites (Fig. S1A ), which were subsequently crossed with mice expressing Cre downstream of either the proximal LCK promoter (lck-cre) or the CD4 promoter (CD4-cre) to delete Sos1 at the DN2/DN3 or the DN4/DP transitions, respectively (18) . Targeting was confirmed via Southern and Western blotting ( Fig. S1 B and C) . Efficient Sos1 deletion at the DP stage was obtained using lck-cre, but not CD4-cre (Fig. S1 C and D) . We therefore used lck-cre to delete Sos1 for thymic developmental studies. Because lck-cre expression can affect thymic cellularity (19) Compared with Sos1 +/+ mice, Sos1 −/− (T) mice showed a 50% reduction in total thymocyte numbers (Fig. 1A) . Staining with anti-CD4 and anti-CD8 revealed an increase in the percentage of DN thymocytes in Sos1 −/− (T) mice (Fig. 1B) , although the total number of DN thymocytes was reduced (Fig. 1C, and see below) . We saw a significant reduction in the numbers of DP, CD4SP, and CD8SP thymocytes (Fig. 1C) , indicating a potential block at the DN-to-DP transition after sos1 deletion. Interestingly, the numbers of peripheral CD4 + and CD8 + lymph node (LN) T cells were not decreased in Sos1 −/− (T) mice vs. Sos1 +/+ controls ( Fig. S1 E  and F) . Peripheral T-cell development was also normal when Sos1 was deleted using CD4-cre to bypass the early developmental block seen at the DN-DP transition in Sos1
Sos1 Is Required for Normal Development Beyond the DN3 Stage. To assess the role of Sos1 during the four stages of DN thymocyte development, gated DN thymocytes were analyzed by flow cytometry following staining for the cell surface markers CD44 and CD25 (Fig. 1D) . Though there was no significant effect of Sos1 deletion on the numbers of DN1-3 thymic subsets (Fig. 1E) , Sos1 −/− (T) mice consistently showed a reduction in the percentage (Fig. 1D ) and number ( Fig. 1E ) of DN4 cells and an increase in the DN3:DN4 ratio (Fig. 1E ). This decrease in the number of DN4 thymocytes accounts for much of the decrease in total DNs (Fig. 1C) . These data indicate that deletion of Sos1 leads to a developmental block at the point of pre-TCR signaling. This decrease in DN4 cells was not due to either defective TCRβ rearrangement, as assessed by intracellular TCRβ staining (Fig.  S3A) , or a shift in lineage commitment toward γδ T cells (7) , as their absolute number was also decreased by 50% in Sos1 −/− (T) mice (Fig. S3B ). This result indicates that sos1 may also be required for γδ T-cell development. The development of thymic NKT cells, however, was not affected (Fig. S3C ), consistent with a previous study showing that Ras was not required for NKT cell development (20) .
Sos1 Is Required for Pre-TCR-Mediated Proliferation. Development beyond the β-selection checkpoint is accompanied by many pre-TCR-mediated events, including allelic exclusion to ensure each T cell expresses a single TCRβ chain, escape from apoptosis through the activation of survival pathways, a proliferative burst leading to a marked increase in cell numbers expressing the newly rearranged TCRβ chain, and differentiation to the DP stage (8) . The early expression of the TCRβ genes in TCR transgenic mice suppresses rearrangement of endogenous TCRβ alleles if allelic exclusion signals are intact (21) . Using either AND or female HY TCR transgenic mice, we found that Sos1 deletion did not allow expression of a second Vβ gene in mature T cells ( Fig. S3 D and E), consistent with a previous study showing that Ras was not required for allelic exclusion (22) .
The decreased number of DN4 thymocytes seen in the absence of Sos1 (Fig. 1E ) suggested that Sos1 may be required for either pre-TCR-driven cellular survival or expansion. Sos1 expression was not required for pre-TCR-mediated IL-7R expression (Fig.  S4A ), which is thought to be involved in pre-TCR-mediated survival signaling (23) . Sos1 deletion also did not lead to an increase in apoptosis in DN3 or DN4 cells, as assessed by annexin V staining (Fig. S4B) , indicating that the developmental block seen upon sos1 deletion was not due to defective pre-TCRmediated survival signals.
To assess pre-TCR-mediated proliferation following β-selection, Sos1 +/+ and Sos1
−/− (T) mice were injected i.p. with 1 mg BrdU and assessed 18 h later for BrdU incorporation in thymocytes. Whereas BrdU incorporation was equivalent at the DN3 stage, Sos1 −/− (T) mice showed a 25% reduction in BrdU incorporation in both DN4 and DP thymocytes compared with Sos1 +/+ controls (Table 1 and Fig. S5 ), indicating that Sos1 was required for optimal thymocyte proliferation. Because β-selection occurs at the DN3 stage of thymocyte development, these data indicate that Sos1 is required for the proliferative burst seen following β-selection in DN4 cells.
To further assess cell proliferation during T-cell development, Sos1 −/− (T) mice were crossed to Rag2 −/− mice, and assessed for proliferation and DP differentiation following anti-CD3ε injection (24) . Compared with Sos1 +/+ Rag2 −/− mice, Sos1
−/− mice showed a marked reduction in both proliferation and differentiation into DP cells on a per-cell basis ( Fig. 2A) . These data indicate that Sos1 is required for complete anti-CD3ε-stimulated proliferation and differentiation into DP thymocytes. Ras activation in thymocytes is controlled both by Sos proteins and by RasGRP1 (3, 4, 13) . RasGRP1 −/− mice showed no overall defect in differentiation to the DP stage (14) , but forced overexpression of RasGRP1 at the DN3 stage can drive DP development in Rag2 −/− mice (25) . However, the ability of anti-CD3ε-stimulated Rag2 −/− thymocytes to proliferate in the absence of RasGRP1 has never been assessed. Because Sos1
−/− thymocytes showed a slight, albeit extremely attenuated, ability to proliferate and differentiate into DP thymocytes upon anti-CD3ε injection, we assessed whether RasGRP1 was also required for maximal proliferation and differentiation following anti-CD3ε stimulation in Rag2 −/− mice (Fig. 2B) . In contrast to the extreme attenuation of proliferation seen upon sos1 deletion, RasGRP1 −/− Rag2 −/− mice showed no deficit in either anti-CD3ε-induced proliferation or differentiation into DP thymocytes (Fig. 2B) . These data provide evidence that Sos1, and not RasGRP1, acts as the dominant RasGEF for pre-TCR-mediated proliferative signals.
Sos1 Is Not Required During DP Thymocyte Selection. Once thymocytes differentiate to the DP stage, they undergo a second, TCRmediated developmental program (positive and negative selection) that allows some thymocytes to become mature CD4 + helper or CD8 + effector T cells (9) . To assess whether Sos1 was required for positive selection of either CD4 or CD8 T cells, Sos1 −/− (T) mice were crossed to AND (26) or HY (27) αβTCR transgenic mice. Deletion of sos1 did not affect the development of CD4SP thymocytes in AND + mice (Fig. 3A) , even when crossed onto a Rag2
−/− background to exclude enhanced positive selection due to expression of a second, endogenous Vα chain (Fig. S6 A and B ) (28) . These data show that deletion of sos1 did not affect MHC class II-mediated positive selection. Similar to the results seen in AND + mice, sos1 deletion did not affect the development of CD8SP thymocytes in female HY + mice (Fig. 3B) , indicating that Sos1 expression was also not required for MHC class I-restricted positive selection. Sos1 was also not required for positive selection in mice with a polyclonal TCR repertoire, as assessed by examining expression levels of the cell surface markers CD3ε, TCRβ, CD24, and CD69 during thymocyte development (Fig. S6 C and D) .
To begin to assess negative selection, we analyzed thymocyte development in HY + male mice. HY mice express a high-affinity TCR early in thymocyte development that recognizes a malespecific peptide in the context of MHC class I. Though this premature TCR expression is advantageous in assessing allelic exclusion (Fig. S3E) , in male mice HY expression causes strong signaling and negative selection early in DP thymocytes, rather than at the DP-SP transition (27, 29) . Negative selection, as assessed by loss of DP thymocytes and the absence of CD8SP thymocytes, proceeded as (or more) efficiently in HY + Sos1 −/− (T) male mice compared with HY + controls (Fig. 3C ), indicating that negative selection induced by a strong ligand occurs in the absence of Sos1. To further assess negative selection, superantigen SEB-induced deletion of Vβ8 + thymocytes was analyzed (30) . SEB-induced negative selection was equally efficient in both Sos1 +/+ and Sos1
−/− (T) mice (Fig. 3D ), indicating that Sos1 was not required in a second, classical model of negative selection. As an internal control, SEB did not cause deletion of Vβ6 + thymocytes in either Sos1 +/+ or Sos1 −/− (T) mice, indicating that SEB treatment caused specific, rather than systemic, TCR activation. In addition, deletion of Sos1 did not affect DP thymocyte death either in vivo following IP anti-CD3ε injection (Fig. S7A) S7B). These data indicate that there is not a selective survival disadvantage to DP thymocytes upon Sos1 deletion.
Sos1 Is Preferentially Required for Signal Transduction Early in
Thymocyte Development. Our findings suggest that Sos1 is selectively required for developmental signals coming from the pre-TCR early in thymocyte development (Fig. 1 ), but not from the mature TCR during positive and negative selection (Fig. 3) . To directly address whether Sos1 was preferentially required for pre-TCR-, but not TCR-mediated signaling, we assessed anti-CD3ε-stimulated ERK activation in the presence or absence of Sos1 at different stages of T-cell development as a measure of signaling downstream of Ras. Sos1 expression was required for anti-CD3ε-stimulated ERK phosphorylation in Rag2 −/− (DN3) thymocytes (Fig. 4A) . Furthermore, in the absence of Sos1, basal ERK activation was reduced by 50% in Rag2 −/− thymocytes. These data confirm a role for Sos1 in signaling to ERK at the DN3 stage.
In contrast, Sos1 was progressively less relevant to anti-CD3ε-stimulated ERK activation as the T-cell population matured. In DP thymocytes, ERK activation was readily detectable in cells isolated from Sos1 −/− (T) mice, although deletion of Sos1 led to a 30-40% reduction in maximal ERK activation vs. WT controls at multiple doses of anti-CD3ε stimulation ( Fig. 4B and Fig. S8A ). Furthermore, in CD4 + LN T cells or CD4SP thymocytes, deletion of Sos1 showed only a 10-15% decrease in ERK phosphorylation ( Fig. 4C and Fig. S8B ), consistent with previous studies (31) . Collectively, these data suggest a requirement for Sos1 in developmental signaling at the DN3 stage (Fig. 1) , but a diminished role for Sos1 in signal transduction required for positive and negative selection (Fig. 3) or for peripheral T-cell development (Figs. S1 and S2) .
Previous studies showed that RasGRP1 was preferentially required for TCR-, but not pre-TCR-mediated development, and that expression of RasGRP1 was induced fourfold between the DN3 and DP developmental stages (14) . To assess whether the early, but not late, developmental and signaling requirements for Sos1 could similarly be attributed to differences in expression at different developmental stages, we assessed the relative expression levels of Sos1 and RasGRP1 in DN3 thymocytes, DP thymocytes, and CD4 + LN cells purified from Rag2 −/− thymus, B6 thymus, or B6 LN, respectively (Fig. 5) . The relative expression of RasGEFs was directly compared after normalization to cellular β-actin levels. Surprisingly, we observed a fivefold decrease in Sos1 expression levels between the DN3 and DP developmental stages as assessed by Western blotting. In agreement with previously published data, we also saw a fivefold increase in RasGRP1 expression between the DN3 and DP stages (Fig. 5) . These data show a marked shift in the availability of Sos1 vs. RasGRP1 to signaling pathways downstream of the pre-TCR vs. the mature TCR, showing a 25-fold change in the Sos1:RasGRP1 ratio from the DN3 to the DP stage (Fig. S9A) . We also assayed Sos2 levels in these samples to test whether Sos2 could compensate for relative decreases in Sos1 levels during development. In contrast to Sos1, Sos2 expression levels steadily decreased during T-cell development (Fig. 5) , such that relative to Sos1, Sos2 is most abundant at the DP stage (Fig. S9B) . Furthermore, there was not a compensatory increase in Sos2 expression upon sos1 deletion (Fig.  S9C) . These data support a role for Sos1 specifically during pre-TCR-mediated developmental signaling.
Discussion
We have generated a floxed allele of sos1, and its thymocytespecific deletion shows that Sos1 expression is required for pre-TCR-mediated proliferative and developmental signaling. Deletion of Sos1 early in thymocyte development caused a 50% reduction in overall thymocyte numbers and a partial block at the DN-to-DP transition. However, Sos1 was not required for developmental signaling through the mature TCR. Analysis of RasGEF expression at different developmental stages showed a marked shift in Sos1 vs. RasGRP1 expression between DN3 and DP thymocytes. These data reveal that of these two RasGEFs, Sos1 is uniquely positioned to affect signal transduction early, but not late, in thymocyte development under strong negative selection conditions. These data further suggest that the developmental regulation of RasGEFs can shape the output of Ras signal transduction to affect thymocyte development.
Genetic studies have defined a pathway required for development beyond the DN3 stage from pre-TCR/CD3 complexes, via the Src and Syk family kinases, through the adaptors LAT and Slp76, to multiple downstream effectors (8) . Deletion of either LAT or Slp76 leads to a complete developmental block at the DN3 stage (11, 12) . However, the Src kinases (Lck and Fyn) and the Syk kinases (Syk and Zap70) show both unique and over- lapping functions during thymocyte development (32) (33) (34) (35) , and changes in the expression levels of Lck or Fyn and Syk or Zap70 seem to, in part, underlie these developmental changes in enzyme use (35) (36) (37) . Furthermore, combined deletion of either the Src (33, 38) or Syk (32) kinases is required for a complete DN3 developmental block. Similarly, our data show that for the RasGEFs, Sos1 is dominant for early, pre-TCR-mediated developmental signals, whereas RasGRP1 seems dominant for ERK activation and development at the DP stage (14) . During intrathymic development, changes in the expression levels of Sos1 and RasGRP1 occur that may account for their changing importance (Fig. 5) . However, as with the Lck/Fyn and Syk/Zap70 pairs, a combination of Sos1, Sos2, RasGRP1, and other RasGEF knockouts may be required to achieve a complete DN3 block. The RasGEFs Sos1 (widely expressed) and RasGRF1/2 (tissuelimited expression) control Ras activation in the CNS. Developmental studies showed that Sos1 levels are high and RasGRF levels are low in neonatal cortical brain slices, whereas Sos1 levels are low and RasGRF levels are high in the adult cortex. In addition, studies of RasGRF1
RasGRF2
−/− mice showed that RasGRF1 and RasGRF2 are required for NMDA-induced ERK activation in adult, but not neonatal, cortex (39) . These findings suggest that Sos1 may be most important to Ras activation early in developmental programs. Furthermore, the developmental regulation of Sos1 vs. tissue-specific RasGEFs may be a more generalized phenomenon than has previously been appreciated.
When assessing development at the DP stage, our data show that Sos1 expression was not required for negative selection in vivo induced by the HY antigen in male mice, or by either SEB or anti-CD3ε injection (Fig. 3 and Fig. S7 ). However, each of these models has its own set of limitations (29, 40) . The HY antigen and anti-CD3ε injection are very strong stimuli that lead to premature negative selection at the DP stage, and superantigens such as SEB interact with the TCR differently from the normal peptide-MHC interaction. Furthermore, though these same models have been invaluable in elucidating many of signaling pathways involved in negative selection, they have failed to establish whether signal transduction via the Ras/ERK pathway plays a role in negative selection (6, 20, 41) .
Additional experiments probing the role of the RasGEFRas-ERK pathway in positive and negative selection have led to an interesting model. Studies using fetal thymic organ cultures from OT-I transgenic mice showed a correlation between weak, Ras-GRP1-dependent Ras/ERK activation during positive selection and strong, Sos-dependent Ras/ERK activation during negative selection (4) . Furthermore, recent studies have proposed a positive feedback loop between RasGRP1 and Sos that is engaged during Ras activation (31, 42) . Together, these studies have suggested a hypothesis whereby in DP thymocytes, low-potency ligands signal via RasGRP1 to promote positive selection, whereas stronger ligands engage both RasGRP1 and Sos, resulting in a sharp increase in signal amplitude and negative selection (13) .
A key point of this model is that engagement of Sos should define both the threshold between positive and negative selection and its character (sharp vs. graded). Though our current study does not directly assess the role Sos1 plays in setting this threshold, our data do set certain constraints upon this model. The expression levels of RasGRP1 and Sos1 seen at the DP stage (Fig. 5) show that these RasGEFs are potentially poised to maximize a sharp boundary between positive and negative selection. High levels of RasGRP1 both favors the use of this RasGEF by low-potency ligands and lowers the threshold for engaging Sos, whereas low levels of Sos1 lessen the amount of Ras-GTP required to fully engage Sos1. These points are not in conflict with the current model. This model, however, also predicts profound defects in negative selection in the absence of Sos (13). Though we do see a 40% reduction of TCR-stimulated ERK activity in Sos1 −/− (T) DP thymocytes (Fig. 4B) , which might be sufficient to alter either the level or character of a threshold between positive and negative selection, we do not see an effect of Sos1 deletion on negative selection induced by high-potency ligands (Fig. 3 C and D) . These data suggest that signaling through RasGRP1 alone or in combination with Sos2 (see below) must be sufficient for negative selection under strong stimulatory conditions. These constraints must be factored into future models assessing the role of Ras signaling during thymocyte selection.
Though the current study focuses nearly exclusively on Sos1, T cells express two highly homologous family members, Sos1 and Sos2. Although both family members can activate Ras, they have unique signaling properties that may allow them to differentially affect thymocyte development (43, 44) . Analysis of Sos2 expression revealed a more gradual decrease in Sos2 levels during T-cell development than was seen for Sos1, such that the relative ratio of Sos2:Sos1, compared with β-actin levels, was equivalent in DN3 and CD4 + LN cells, but increased specifically in DP thymoyctes (Fig. S9B) . These data suggest that Sos2, and not Sos1, may be the more relevant Sos family member at the DP stage. However, a detailed study using double-and triple-Sos1, -Sos2, and RasGRP1 knockout mice, in a titratable system such as OT-I, will be required to fully appreciate the role of these RasGEFs during thymocyte development.
Interestingly, in peripheral CD4 + T cells, where Sos1 was least important for ERK activation, the levels of both RasGRP1 and Sos2 paradoxically decreased. This would suggest that Sos1 should be more important at this stage for signaling to the Ras/ERK cascade. However, signal transduction to Ras may depend on RasGEFs other than Sos and RasGRP in mature lymphocytes. Though we only assess the expression of Sos1, Sos2, and RasGRP1, lymphocytes express a number of other RasGEFs, including RasGRF2. Previous studies have shown that the RasGRF2 participates in TCR signaling specifically in mature lymphocytes (45) . However, whether RasGRF2, Sos2, or other RasGEFs can explain the reduced requirement for Sos1 during signal transduction in peripheral cells, seen in both our study and previously in cell culture models (31) , requires further examination.
Grb2 is constitutively associated with Sos1, and the phenotype of Grb2 and Sos1 knockout mice was similar (16, 17, 46) . However, though Grb2 expression is required in several classical models of negative selection (HY + male mice, SEB injection, and anti-CD3ε injection) (47, 48) , as discussed previously, Sos1 was dispensable for these same processes. These data suggest either functional redundancy via Sos2 or that additional, Sos-independent, signaling proteins may transduce signals downstream of Grb2 at the DP stage. One such candidate is Themis, a recently identified Grb2-interacting, T-cell-specific gene required for positive and negative selection (49) (50) (51) . Similar to Grb2 −/− mice, Themis −/− mice showed defective negative selection in HY + male mice and following SEB injection (51) . These data suggest that a Grb2-Themis complex may be as or more relevant than a Grb2-Sos complex in these classical models of negative selection. Furthermore, though elevated Ras/ERK signaling is correlated with negative selection (4), genetic studies have failed to show a direct role for Ras or ERK during negative selection (6, 20, 41) . Because neither Themis nor Grb2 is required for activation of the Ras/ERK pathway at the DP stage (47, 51) , in view of the discussion above and here, one may question the importance of the Ras/ERK pathway during thymocyte negative selection.
Grb2/Sos is central to signal transduction following growth factor engagement of receptor tyrosine kinases (RTKs) (1) . Members of many of these same RTK systems are mutationally activated in a variety of cancers (52) , and it has been hypothesized that signal transduction through Ras is deregulated in most cancers (2) . Targeted deletion of either Grb2 or Sos1 in mouse models where RTK mutations drive tumorigenesis would allow for a better understanding of which RasGEFs lead to Ras activation, and may enable the development of more refined, targeted therapeutics.
In summary, we have identified a role for Sos1 in pre-TCR-but not TCR-mediated developmental signaling under strongly stimulatory conditions. Additional studies are needed to gain a complete understanding of which combinations of RasGEFs are required for thymocyte development. Finally, we have generated a unique mouse model that will allow a more complete understanding of the requirements of Sos1 not only in thymic development, but also in numerous other signaling, oncogenic, and developmental systems.
Materials and Methods
The Sos1 targeting vector was produced via recombineering as detailed in SI Materials and Methods (53) . Two independent lines of sos1-targeted mice were generated, with identical results for each founder line. All other materials and methods can be found in SI Materials and Methods.
